Æterna Zentaris, Inc.
(Toronto Stock Exchange : AEZS)

( )
AEZS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.95%69.150.0%$1917.83m
NVAXNovavax, Inc. 9.93%146.5196.5%$1301.01m
SRNESorrento Therapeutics, Inc. -4.38%12.441.5%$767.50m
GILDGilead Sciences, Inc. 0.47%68.501.0%$580.36m
AMGNAmgen, Inc. 0.36%239.711.3%$465.88m
REGNRegeneron Pharmaceuticals, Inc. 0.28%612.572.7%$378.37m
VRTXVertex Pharmaceuticals, Inc. 0.05%267.291.9%$351.81m
BIIBBiogen, Inc. 0.32%289.451.4%$344.47m
ILMNIllumina, Inc. -1.69%347.563.5%$340.75m
BNTXBioNTech SE -3.32%68.640.0%$334.95m
ATNMActinium Pharmaceuticals, Inc. -1.21%9.7913.3%$231.53m
EBSEmergent BioSolutions, Inc. -1.09%133.476.4%$198.26m
VXRTVaxart, Inc. 0.55%9.140.0%$194.27m
MCRBSeres Therapeutics, Inc. -4.62%27.263.6%$181.12m
ALXNAlexion Pharmaceuticals, Inc. 1.06%102.971.9%$162.43m

Company Profile

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.